annual EBIT:
-$143.09M-$88.97M(-164.38%)Summary
- As of today (June 17, 2025), MLTX annual earnings before interest & taxes is -$143.09 million, with the most recent change of -$88.97 million (-164.38%) on December 31, 2024.
- MLTX annual EBIT is now -164.38% below its all-time high of -$54.12 million, reached on December 31, 2023.
Performance
MLTX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$40.39M+$9.19M(+18.54%)Summary
- As of today (June 17, 2025), MLTX quarterly earnings before interest & taxes is -$40.39 million, with the most recent change of +$9.19 million (+18.54%) on March 31, 2025.
- Over the past year, MLTX quarterly EBIT has dropped by -$26.48 million (-190.46%).
- MLTX quarterly EBIT is now -544.43% below its all-time high of -$6.27 million, reached on September 30, 2021.
Performance
MLTX quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$163.66M-$26.48M(-19.31%)Summary
- As of today (June 17, 2025), MLTX TTM earnings before interest & taxes is -$163.66 million, with the most recent change of -$26.48 million (-19.31%) on March 31, 2025.
- Over the past year, MLTX TTM EBIT has dropped by -$108.56 million (-197.04%).
- MLTX TTM EBIT is now -400.76% below its all-time high of -$32.68 million, reached on June 30, 2021.
Performance
MLTX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
MLTX EBIT Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -164.4% | -190.5% | -197.0% |
3 y3 years | - | -153.3% | -198.2% |
5 y5 years | - | -23.6% | -400.8% |
MLTX EBIT Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -164.4% | at low | -212.3% | +18.5% | -310.6% | at low |
5 y | 5-year | -164.4% | at low | -544.4% | +18.5% | -400.8% | at low |
alltime | all time | -164.4% | at low | -544.4% | +18.5% | -400.8% | at low |
MLTX EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | -$40.39M(-18.5%) | -$163.66M(+19.3%) |
Dec 2024 | -$143.09M(+164.4%) | -$49.58M(+15.0%) | -$137.18M(+33.7%) |
Sep 2024 | - | -$43.11M(+41.0%) | -$102.62M(+41.6%) |
Jun 2024 | - | -$30.58M(+119.9%) | -$72.49M(+31.6%) |
Mar 2024 | - | -$13.90M(-7.5%) | -$55.10M(+1.8%) |
Dec 2023 | -$54.12M | -$15.03M(+15.8%) | -$54.12M(-3.0%) |
Sep 2023 | - | -$12.98M(-1.6%) | -$55.79M(-3.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2023 | - | -$13.19M(+2.0%) | -$57.58M(-7.2%) |
Mar 2023 | - | -$12.93M(-22.5%) | -$62.05M(-4.6%) |
Dec 2022 | -$65.06M | -$16.70M(+13.0%) | -$65.06M(+34.5%) |
Sep 2022 | - | -$14.77M(-16.3%) | -$48.37M(+21.3%) |
Jun 2022 | - | -$17.65M(+10.7%) | -$39.86M(-27.4%) |
Mar 2022 | - | -$15.94M(+154.4%) | -$54.89M(+40.9%) |
Sep 2021 | - | -$6.27M(-80.8%) | -$38.95M(+19.2%) |
Jun 2021 | - | -$32.68M | -$32.68M |
FAQ
- What is MoonLake Immunotherapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual EBIT year-on-year change?
- What is MoonLake Immunotherapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly EBIT year-on-year change?
- What is MoonLake Immunotherapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics TTM EBIT year-on-year change?
What is MoonLake Immunotherapeutics annual earnings before interest & taxes?
The current annual EBIT of MLTX is -$143.09M
What is the all time high annual EBIT for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual earnings before interest & taxes is -$54.12M
What is MoonLake Immunotherapeutics annual EBIT year-on-year change?
Over the past year, MLTX annual earnings before interest & taxes has changed by -$88.97M (-164.38%)
What is MoonLake Immunotherapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of MLTX is -$40.39M
What is the all time high quarterly EBIT for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly earnings before interest & taxes is -$6.27M
What is MoonLake Immunotherapeutics quarterly EBIT year-on-year change?
Over the past year, MLTX quarterly earnings before interest & taxes has changed by -$26.48M (-190.46%)
What is MoonLake Immunotherapeutics TTM earnings before interest & taxes?
The current TTM EBIT of MLTX is -$163.66M
What is the all time high TTM EBIT for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high TTM earnings before interest & taxes is -$32.68M
What is MoonLake Immunotherapeutics TTM EBIT year-on-year change?
Over the past year, MLTX TTM earnings before interest & taxes has changed by -$108.56M (-197.04%)